<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03682614</url>
  </required_header>
  <id_info>
    <org_study_id>P2018010</org_study_id>
    <nct_id>NCT03682614</nct_id>
  </id_info>
  <brief_title>Effect of Intrauterine Injection of HCG on Clinical Pregnancy Outcome in Repeated Implantation Failure Patients</brief_title>
  <official_title>Effect of Intrauterine Injection of Human Chorionic Gonadotropin Before Embryo Transfer on Clinical Pregnancy Outcome in Repeated Implantation Failure Patients With Normal Pathohistological Stage --Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Reproductive &amp; Genetic Hospital of CITIC-Xiangya</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Reproductive &amp; Genetic Hospital of CITIC-Xiangya</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Repeated implantation failure（RIF） is a insurmountable bottleneck in assisted reproductive
      technology, many studies have considered that the cause of two-thirds of implantation failure
      is the decreased endometrial receptivity. After exclude some major local immune
      factors(NK,CD138 cells) and implantation window out of phase, There are still a part of
      patients infertile .Human chorionic gonadotropin (hCG) is an early pre-implantation signal
      molecule secreted by the embryo, it can promote endometrial proliferation, increase blood
      flow and promote embryonic adhesion and inhibit self-regulated apoptosis of trophoblast
      cells. Previous studies showed that: intrauterine injection of HCG before embryo transfer can
      improve clinical outcomes in IVF/Intracytoplasmic sperm injection(ICSI). But some studies
      found that the intrauterine injection of HCG can not significantly improve the success rate
      of blastocyst transfer, and the reason may be the intrauterine injection of HCG time is too
      late to significantly increase the implantation rate. Would ahead of intrauterine injection
      of HCG be more effective? Thus, the patients of repeated implantation frozen embryo cycle
      according to the random principle accepted two kinds of transplants ways: ①intrauterine
      injection of HCG before blastocyst transfer; ②blastocyst transfer. Try to understand whether
      intrauterine injection of HCG can significantly improve the clinical pregnancy rate of
      blastocyst transfer in repeated implantation failure patients.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 10, 2018</start_date>
  <completion_date type="Actual">October 16, 2019</completion_date>
  <primary_completion_date type="Actual">August 18, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>clinical pregnancy rate</measure>
    <time_frame>28 days after blastocyst transfer</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>clinical implantation rate</measure>
    <time_frame>28 days after blastocyst transfer</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ongoing pregnancy rate</measure>
    <time_frame>70 days after blastocyst transfer</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ectopic pregnancy rate</measure>
    <time_frame>within 3 months after blastocyst transfer</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>abortion rate</measure>
    <time_frame>within 28 weeks after blastocyst transfer</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">47</enrollment>
  <condition>Infertility</condition>
  <arm_group>
    <arm_group_label>HCG group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>All patients will accept HCG 500IU intrauterine injection 2 days before blastocyte transfer</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>All patients will accept same dose of culture medium intrauterine injection 2 days before blastocyte transfer</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>HCG</intervention_name>
    <description>we will use the catheter to pass through the cervix, and after that, the experiment Group will accept 40 μl 500 IU HCG injection into the uterine cavity 2 days before the blastocyst transfer.</description>
    <arm_group_label>HCG group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>culture medium</intervention_name>
    <description>The placebo group will accept 40 μl of culture medium injection into the uterine cavity 2 days before the blastocyst transfer.</description>
    <arm_group_label>control group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  repeated implantation failure patients: ≥ 3 times IVF-embryo transfer failed to help
             pregnancy (biochemical or non-pregnant)

          -  age ≤36 years old

          -  normal histopathological stage (+5-7)

          -  endometrial NK cell ＜4.5%

          -  0 endometrial CD138 positive cell

          -  natural cycle frozen embryo transfer

          -  frozen blastocysts (≥4BC) embryos ≥ 1

        Exclusion Criteria:

          -  Scar uterus (diverticulum or incision false lumen after cesarean section)

          -  intrauterine adhesions

          -  untreated hydrosalpinx

          -  adenomyosis (endometrial displacement)

          -  endometritis

          -  uterine fibroids compress the endometrium
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>36 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Reproductive &amp; Genetic Hospital of CITIC-XIANGYA</name>
      <address>
        <city>Changsha</city>
        <state>Hunan</state>
        <zip>410000</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>November 2019</verification_date>
  <study_first_submitted>September 18, 2018</study_first_submitted>
  <study_first_submitted_qc>September 21, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">September 24, 2018</study_first_posted>
  <last_update_submitted>November 2, 2019</last_update_submitted>
  <last_update_submitted_qc>November 2, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">November 5, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infertility</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

